D. E. Shaw & Co., Inc. Marker Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.46 $4,183 - $7,401	-16,090 Reduced 16.38%	82,117 $27,000
Q1 2022 May 16, 2022	SELL	$0.37 - $1.0 $142,515 - $385,178	-385,178 Reduced 79.68%	98,207 $43,000
Q4 2021 Feb 14, 2022	BUY	$0.95 - $1.72 $25,975 - $47,029	27,343 Added 6.0%	483,385 $459,000
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $294,253 - $504,434	-175,151 Reduced 27.75%	456,042 $771,000
Q2 2021 Aug 16, 2021	BUY	$1.88 - $3.56 $1.14 Million - $2.15 Million	603,794 Added 2203.71%	631,193 $1.76 Million
Q1 2021 May 17, 2021	SELL	$1.47 - $3.29 $998 - $2,233	-679 Reduced 2.42%	27,399 $61,000
Q4 2020 Feb 16, 2021	BUY	$1.36 - $1.75 $38,186 - $49,136	28,078 New	28,078 $41,000
Q2 2020 Aug 14, 2020	SELL	$1.69 - $2.79 $59,755 - $98,648	-35,358 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.59 - $3.35 $16,569 - $34,910	10,421 Added 41.79%	35,358 $67,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $66,831 - $120,944	24,937 New	24,937 $72,000
Q3 2019 Nov 14, 2019	SELL	$4.1 - $9.0 $60,630 - $133,092	-14,788 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $76,158 - $117,120	14,788 New	14,788 $117,000
Q1 2019 May 15, 2019	SELL	$5.1 - $6.71 $52,086 - $68,529	-10,213 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.2 - $9.74 $42,894 - $99,474	10,213 New	10,213 $57,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $269M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.